Healthy Clinical Trial
Official title:
The Vascular and Cognitive Effects of Chronic High-flavanol Intake in Healthy Males
Verified date | May 2016 |
Source | University of Reading |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Interventional |
A randomised, placebo-controlled, parallel human dietary intervention trial conducted in 33 healthy males to investigate the vascular and cognitive effects of bi-daily consumption of high-flavanol (epicatechin-rich) milk chocolate over a 2-week intervention period. Subjects visited the Hugh Sinclair Unit of Human Nutrition on 3 separate occasions; at the beginning, end and post-intervention.
Status | Active, not recruiting |
Enrollment | 34 |
Est. completion date | June 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria - Body Mass Index 18.5-27.5 kg/m2 - Normal Blood pressure (< 150/90) - Non-smoker - Regular exercise routine - Signed consent form Exclusion Criteria: - Haemoglobin (anaemia marker) < 125 g/l - Gamma GT (liver enzymes) > 80 IU/l - Total Cholesterol > 6.5 mmol/l - Suffered a myocardial infarction or stroke in the last 12 months - Suffers from any cardiovascular or metabolic disorders - Suffers from any blood-clotting disorder, and/or takes supporting medication - Any dietary restrictions or on a weight reducing diet - On any lipid-modifying or blood pressure lowering medication - Consuming any specific vitamin/ herbal supplements or fish oils |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Reading |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Flow-mediated Dilation (FMD) | Ultrasound-based assessment of brachial artery reactivity following induced reactive hyperemia | Change from baseline at 14 days | No |
Secondary | Blood pressure (BP) | Acute assessment of systolic and diastolic BP (3 repeats) | Change from baseline at 14 days | No |
Secondary | Executive Function | Assessed by cognitive test battery | Change from baseline at 14 days | No |
Secondary | Endothelial progenitor cells and Microparticles | Flow cytometric analysis using whole blood | Change from baseline at 14 days | No |
Secondary | Plasma flavanol metabolite analysis | HPLC-MS assessment of metabolite profile and content of plasma | Change from baseline at 14 days | No |
Secondary | Plasma Nitrite & Nitrate analysis | HPLC-based system with inbuilt colorimetric Griess reaction assay for the assessment of Nitrite & Nitrate in plasma | Change from baseline at 14 days | No |
Secondary | Serum analysis of cardivascular-related blood marker(s) concentration | ILAB assessment of serum content of glucose, Triglycerides, total cholesterol, HDL-cholesterol, C-reactive protein and Non-esterified fatty acids | Change from baseline at 14 days | No |
Secondary | Serum analysis of insulin | ELIZA kits for determination of insulin concentration in serum | Change from baseline at 14 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |